Price of J&J’s TB drug to drop by more than half

Life-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient —over 50% cheaper than the earlier price of $900.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2N5NtII
via IFTTT

0 comments:

Post a Comment